7QA-33930-98206
3 vaccinations
11 coded responses
26 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 846 / UT
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Survey response — day 0, dose 1MedDRA: Colitis ulcerative, Hypertension, Hypothyroidism, Spondyloarthropathy, Type 2 diabetes mellitus — Feeling: Fair · Joint painsFree text: UC, hypertension, spondyloarthropathy, hypothyroidism, diabetes type 2MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease, Unevaluable event — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: Just the autoimmune and chronic stuffMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Myalgia — Feeling: Good · Muscle or body achesFree text: Muscle and joint pains are normal for me, they are not bad at all today.notMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Arthropathy — Feeling: Good · Joint painsFree text: Just the usual joint issues. Nothing more.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Joint painsFree text: Normal pains, nothing new.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-11
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Pre-existing disease, Urticaria — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Hives on neck and legs; asthma flare-upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Good · HeadacheFree text: Cough on day 2, none day 3, then cough again Days 4 & 5MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Fatigue — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Cough, extreme fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-26
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
- 2021-08-12
-
2021-08-20
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — day 35, dose 3MedDRA: Asthma, Pre-existing disease — Feeling: GoodFree text: Worsening asthma. Spirometry done, added two more puffs/day of Symbicort.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — day 42, dose 3MedDRA: Asthma, Pre-existing disease — Feeling: GoodFree text: Asthma increased.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-08-20 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): UC, hypertension, spondyloarthropathy, hypothyroidism, diabetes type 2
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Just the autoimmune and chronic stuff
Systemic reaction (other): Muscle and joint pains are normal for me, they are not bad at all today.not
Systemic reaction (other): Just the usual joint issues. Nothing more.
Systemic reaction (other): Normal pains, nothing new.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Hives on neck and legs; asthma flare-up
Systemic reaction (other): Cough on day 2, none day 3, then cough again Days 4 & 5
Systemic reaction (other): Cough, extreme fatigue
Release 9 — day 35, dose 3
Symptoms: Worsening asthma. Spirometry done, added two more puffs/day of Symbicort.
Release 9 — day 42, dose 3
Symptoms: Asthma increased.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Arthropathy | ✓ | ✓ | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Colitis ulcerative | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Hypertension | ✓ | ✓ | ✓ |
| SRO | Hypothyroidism | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Spondyloarthropathy | ✓ | ✓ | ✓ |
| SRO | Type 2 diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release